VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,153,218
- Total 13F shares
- 234,301,041
- Share change
- -295,810
- Total reported value
- $108,951,765,309
- Put/Call ratio
- 86%
- Price per share
- $465.08
- Number of holders
- 1,532
- Value change
- -$108,863,209
- Number of buys
- 722
- Number of sells
- 679
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
11%
|
26,707,966
|
$12,518,647,409 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9%
|
22,975,521
|
$10,769,086,204 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.4%
|
21,312,244
|
$9,989,475,160 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
11,726,076
|
$5,496,246,343 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
4.2%
|
10,729,428
|
$5,029,097,436 | — | 30 Jun 2024 | |
| Capital Research Global Investors |
13F
|
Company |
3.4%
|
8,539,339
|
$4,002,584,117 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.8%
|
7,221,072
|
$3,384,660,868 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.6%
|
6,599,785
|
$3,093,451,712 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
6,325,308
|
$2,958,270,258 | — | 30 Jun 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.8%
|
4,699,332
|
$2,202,671,067 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.6%
|
4,094,449
|
$1,919,150,135 | — | 30 Jun 2024 | |
| Amundi |
13F
|
Individual |
1.4%
|
3,504,059
|
$1,647,684,452 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
3,429,086
|
$1,607,281,190 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
3,258,628
|
$1,527,385,719 | — | 30 Jun 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.2%
|
3,142,171
|
$1,472,799,000 | — | 30 Jun 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.1%
|
2,746,012
|
$1,287,110,745 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1%
|
2,584,327
|
$1,211,325,751 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
2,572,485
|
$1,205,775,287 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
2,533,904
|
$1,187,691,484 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.95%
|
2,416,717
|
$1,132,730,108 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.87%
|
2,211,674
|
$1,036,657,000 | — | 30 Jun 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.82%
|
2,090,704
|
$979,954,873 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.81%
|
2,062,499
|
$966,734,563 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.81%
|
2,054,781
|
$963,129,606 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.78%
|
1,972,375
|
$924,490,052 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.72%
|
1,837,650
|
$861,343,236 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.71%
|
1,802,742
|
$844,981,300 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.66%
|
1,681,600
|
$788,198,000 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.63%
|
1,605,986
|
$752,757,729 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.62%
|
1,566,388
|
$734,197,383 | — | 30 Jun 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.58%
|
1,482,676
|
$694,623,070 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.54%
|
1,379,320
|
$646,514,869 | — | 30 Jun 2024 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.47%
|
1,184,408
|
$555,173,170 | — | 30 Jun 2024 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.43%
|
1,091,299
|
$511,510,049 | — | 30 Jun 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.4%
|
1,012,058
|
$474,371,826 | — | 30 Jun 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.36%
|
904,742
|
$425,144,301 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
845,662
|
$396,378,694 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.32%
|
818,364
|
$383,583,858 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.32%
|
804,350
|
$377,014,932 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
0.3%
|
764,800
|
$358,477,056 | — | 30 Jun 2024 | |
| Swedbank AB |
13F
|
Company |
0.26%
|
666,212
|
$312,266,885 | — | 30 Jun 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
665,382
|
$311,877,851 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.26%
|
662,957
|
$310,767,965 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.25%
|
633,575
|
$296,969,274 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.23%
|
594,380
|
$278,597,794 | — | 30 Jun 2024 | |
| Bellevue Group AG |
13F
|
Company |
0.23%
|
593,461
|
$278,167,040 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.23%
|
586,322
|
$274,820,848 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.22%
|
563,356
|
$264,056,224 | — | 30 Jun 2024 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.22%
|
555,665
|
$260,451,306 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.22%
|
552,414
|
$258,927,395 | — | 30 Jun 2024 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2024
As of 30 Sep 2024,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,532 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
234,301,041 shares.
The largest 10 holders included
Capital World Investors, VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, FMR LLC, Capital Research Global Investors, ALLIANCEBERNSTEIN L.P., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and JENNISON ASSOCIATES LLC.
This page lists
1,536
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
1,538
Q3 2024 holders
1,532
Holder diff
-6
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.